Based on clinical trials with 240 adult
and pediatric patients (12+ years)
with EoE at Week 24
Treatment for EoE
Eosinophilic esophagitis (EoE) is a chronic condition that can damage the esophagus over time. People with EoE
have more inflammation than normal in the esophagus, leading to difficulty swallowing and other symptoms.
Pills, slurries, and food elimination diets may provide symptom relief.
DUPIXENT helps reduce EoE symptoms.
The First and only FDA approved treatment
option for EoE
DUPIXENT was studied in a pair of 24-week clinical trials with adults and pediatric patients aged 12-17 who weigh at least 88 lb (40 kg) with eosinophilic esophagitis (EoE), most of whom had a history of prior use of swallowed topical corticosteroids for the treatment of EoE.
The DUPIXENT MyWay Copay Card may help eligible patients cover the out-of-pocket cost of DUPIXENT. If you’re eligible, you can sign up and your card will be sent via email. Terms & Restrictions apply.
Find a specialist who
Use this Healthgrades™ tool to easily find
specialists with experience in
Eosinophilic Esophagitis (EoE).
particular physician, and search results do not include a
comprehensive list of doctors in your area.